{
    "2018-03-27": [
        [
            {
                "time": "",
                "original_text": "[推荐评级]医药行业周报：三把“火”有望催化医药“大年”",
                "features": {
                    "keywords": [
                        "医药行业",
                        "周报",
                        "三把火",
                        "催化",
                        "大年"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "【医药丨周小刚】健帆生物(300529)：人工肝市场潜力不亚于肾病， 未来快速放量可期",
                "features": {
                    "keywords": [
                        "健帆生物",
                        "人工肝",
                        "市场潜力",
                        "肾病",
                        "快速放量"
                    ],
                    "sentiment_score": 0.78,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}